DEA MATE Act Substance Use Disorder 4-Activity Package - 25% off

The recently enacted Medication Access and Training Expansion (MATE) Act, requires that Drug Enforcement Administration (DEA)-registered health care providers (except those in exclusive veterinary practice) complete training on the treatment and management of opioid or other substance use disorders.

This mandated eight (8) hours of enduring education is a one-time requirement and can be fulfilled using one or more continuing education (CE) activities related to opioid and other substance use. Evidence of completed education will be requested after June 27, 2023 whenever a provider applies for a new or renewed DEA registration to be a licensed prescriber of controlled substances.

Activity 1 – Defining and Managing Pain

• Describe a multidimensional definition of pain that includes the influences originating from three biopsychosocial dimensions.
• Differentiate between acute, subacute, and chronic pain when describing the pain experience.
• Review the rationale supporting the consistent use of validated assessment instruments when assessing pain.
• Describe the recommended decision process to be used when determining whether or not to initiate opioids for pain management
• Describe the types and formulations of opioid drugs that are recommended for use in an outpatient or community setting.
• Outline potential benefits, risks, and harms when prescribing opioids.
• Describe clinical practice recommendations to prevent patient harm when prescribing opioids.
• Recognize the many nonopioid medications and nonpharmacologic interventions that can be used to treat pain.

Activity 2 – Identifying and Managing Patients with Substance Use Disorder (SUD)

• Discuss the use of validated screening tools and the assessment/diagnosis of individuals who screen positive for substance use disorder.
• Review strategies for the initiation and management of FDA-approved medications for substance use disorder.
• Develop effective patient and family education plans that incorporate how to identify the signs of overdose, patient safety, overdose prevention, and the storage and use of naloxone.

Activity 3 – Safe and Effective Pain Management Utilizing Opioid Therapy

• Review the assessment and treatment of patients with acute, subacute, or chronic pain.
• Develop effective treatment plans and interprofessional treatment interventions.
• List current recommendations and strategies for the management of pain in patients utilizing opioid therapy.
• Recognizing signs and symptoms of opioid use disorder (OUD).

Activity 4 – Overcoming Barriers in the Management of Patients with Opioid Use Disorder (OUD)

• Describe treatment planning techniques using patient-centered decision-making and evidence-based communication strategies.
• Identify the three types of stigmas and their effect on patients with mental health disorders, substance use disorders (SUD), and in particular patients with opioid use disorder (OUD).
• Discuss legal, ethical, and privacy issues involved in the care of clients with opioid use disorder (OUD).

In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

This activity was planned by and for the healthcare team, and learners will receive 8.0 Interprofessional Continuing Education (IPCE) credit for learning and change. 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.0 AAPA Category 1 CME credits. Approval is valid until 6/1/2026. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 8.0 contact hour(s) (which includes 0 hour(s) of pharmacology).

Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

AKH Inc., Advancing Knowledge in Healthcare designates this activity for 8.0 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.